» Articles » PMID: 22075985

Many Stimuli Pull the Necrotic Trigger, an Overview

Overview
Specialty Cell Biology
Date 2011 Nov 15
PMID 22075985
Citations 211
Authors
Affiliations
Soon will be listed here.
Abstract

The lab of Jürg Tschopp was the first to report on the crucial role of receptor-interacting protein kinase 1 (RIPK1) in caspase-independent cell death. Because of this pioneer finding, regulated necrosis and in particular RIPK1/RIPK3 kinase-mediated necrosis, referred to as necroptosis, has become an intensively studied form of regulated cell death. Although necrosis was identified initially as a backup cell death program when apoptosis is blocked, it is now recognized as a cellular defense mechanism against viral infections and as being critically involved in ischemia-reperfusion damage. The observation that RIPK3 ablation rescues embryonic lethality in mice deficient in caspase-8 or Fas-associated-protein-via-a-death-domain demonstrates the crucial role of this apoptotic platform in the negative control of necroptosis during development. Here, we review and discuss commonalities and differences of the increasing list of inducers of regulated necrosis ranging from cytokines, pathogen-associated molecular patterns, to several forms of physicochemical cellular stress. Since the discovery of the crucial role of RIPK1 and RIPK3 in necroptosis, these kinases have become potential therapeutic targets. The availability of new pharmacological inhibitors and transgenic models will allow us to further document the important role of this form of cell death in degenerative, inflammatory and infectious diseases.

Citing Articles

Safety and efficacy of selective RIPK1 inhibitor SIR1-365 in hospitalized patients with severe COVID-19: A multicenter, randomized, double-blind, phase 1b trial.

Chavez-Tapia N, Sayeed M, Luxmi S, Kasper D, Xue F, Shen Y J Intensive Med. 2025; 5(1):70-78.

PMID: 39872839 PMC: 11763862. DOI: 10.1016/j.jointm.2024.07.003.


Receptor-Interacting Protein Kinase-3 Expression Impacts Ocular Vascular Development and Pathological Neovascularization.

Song Y, Wang S, Park S, Hanna B, Johnson K, Darjatmoko S Cells. 2025; 13(24.

PMID: 39768199 PMC: 11726843. DOI: 10.3390/cells13242109.


Expression of RIPK-1 and S-100B in traumatic brain injury- exploring a forensic cases series.

Napoletano G, Marinelli E, Palla L, Zaami S, Maiese A Int J Legal Med. 2024; .

PMID: 39676104 DOI: 10.1007/s00414-024-03400-2.


Role of Pyroptosis in Endometrial Cancer and Its Therapeutic Regulation.

Al Mamun A, Geng P, Wang S, Shao C J Inflamm Res. 2024; 17:7037-7056.

PMID: 39377044 PMC: 11457779. DOI: 10.2147/JIR.S486878.


Investigation and Confirmation of PYCARD as a Potential Biomarker for the Management of Psoriasis Disease.

Xu B, Yu B, Xu Z, Ye S, Qing Y, Sun H J Inflamm Res. 2024; 17:6415-6437.

PMID: 39310902 PMC: 11414756. DOI: 10.2147/JIR.S468746.


References
1.
Knox P, Davies C, Ioannou M, Eliopoulos A . The death domain kinase RIP1 links the immunoregulatory CD40 receptor to apoptotic signaling in carcinomas. J Cell Biol. 2011; 192(3):391-9. PMC: 3101101. DOI: 10.1083/jcb.201003087. View

2.
Li Y, Yang X, Ma C, Qiao J, Zhang C . Necroptosis contributes to the NMDA-induced excitotoxicity in rat's cultured cortical neurons. Neurosci Lett. 2008; 447(2-3):120-3. DOI: 10.1016/j.neulet.2008.08.037. View

3.
Peri P, Nuutila K, Vuorinen T, Saukko P, Hukkanen V . Cathepsins are involved in virus-induced cell death in ICP4 and Us3 deletion mutant herpes simplex virus type 1-infected monocytic cells. J Gen Virol. 2010; 92(Pt 1):173-80. DOI: 10.1099/vir.0.025080-0. View

4.
Ikner A, Ashkenazi A . TWEAK induces apoptosis through a death-signaling complex comprising receptor-interacting protein 1 (RIP1), Fas-associated death domain (FADD), and caspase-8. J Biol Chem. 2011; 286(24):21546-54. PMC: 3122213. DOI: 10.1074/jbc.M110.203745. View

5.
Upton J, Kaiser W, Mocarski E . Virus inhibition of RIP3-dependent necrosis. Cell Host Microbe. 2010; 7(4):302-313. PMC: 4279434. DOI: 10.1016/j.chom.2010.03.006. View